SUGI PHARMACY Umsatz, Kennzahlen, Bilanz/GuV

Um die angezeigten Werte im Chart zu ändern, klicken Sie bitte unten in der Tabelle die entsprechenden Werte an (max. 4 gleichzeitig)

SUGI PHARMACY: Die Aktie (in JPY)

2025202420232022202120202019
141,96121,46103,82104,56113,89112,0795,91
141,96121,46103,82104,56113,89112,0795,91
141,96121,46103,82104,56113,89112,0795,91
35,008,8926,6726,6726,6726,6723,33
293,75-66,670,0000,0000,00014,2916,67
5.127,004.825,004.912,004.944,004.944,004.634,004.379,00

SUGI PHARMACY: Unternehmenskennzahlen (in JPY)

2025202420232022202120202019
4.851,924.114,143.646,643.372,923.249,052.922,552.611,43
19,0319,3418,3020,7221,7215,2016,80
19,0319,3418,3020,7221,7215,2016,80
1,300,381,401,231,081,571,45
50,6459,5361,3063,5957,6658,0362,49
49,3640,4738,7036,4142,3441,9737,51

SUGI PHARMACY: GuV (in Mio. JPY)

2025202420232022202120202019
878.021,00744.477,00667.647,00625.477,00602.510,00541.964,00488.464,00
17,94-6,743,8111,17-6,87
275.043,00228.838,00202.524,00191.490,00181.291,00162.182,00142.300,00
20,19-5,765,6311,78-8,16
42.564,0036.623,0031.659,0032.137,0033.701,0029.762,0025.817,00
16,22--1,49-4,6413,23-4,26
38.079,0032.102,0028.184,0027.456,0031.521,0029.926,0026.053,00
18,62-2,65-12,905,33-6,08
25.689,0021.979,0019.007,0019.389,0021.120,0020.782,0017.940,00
16,88--1,97-8,201,63-9,32

SUGI PHARMACY: Bilanz (in Mio. JPY)

2025202420232022202120202019
244.410,00158.623,00136.709,00122.488,00147.346,00132.153,0099.964,00
156,55121,44108,84107,44102,2288,3078,48
250.704,00233.362,00216.538,00213.890,00200.629,00182.750,00166.563,00
7,437,771,246,619,789,722,79
495.114,00391.985,00353.247,00336.378,00347.975,00314.903,00266.527,00
26,31-5,01-3,3310,50-4,55

SUGI PHARMACY: sonstige Angaben (in JPY)

2025202420232022202120202019
16,8717,00-0,71-8,201,6316,8511,01
16,8717,00-0,71-8,201,6316,8511,01
11.820,008.724,007.727,007.308,006.710,006.182,005.494,00
35,4912,905,738,918,5412,524,39
Die Daten werden von FactSet zur Verfügung gestellt.
FactSet vereinheitlicht die Rechnungslegungsstandards IFRS und US-GAAP, um Unternehmenszahlen branchen- und länderübergreifend vergleichbar zu machen.